Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

NCT07631416 | Not Yet Recruiting Phase 4 DMC

• 1 other identifier: Erector Spinae Plane Block
• Study Type: interventional
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.

Conditions

Post op Pain in Hip Surgeries

Keywords

post op pain in hip surgeries

Outcome Measures

Primary Outcomes (1)

• follow up postoperative pain by Visual Analogue Scale (VAS)score

  follow up postoperative pain every 2hours

  follow up postoperative pain in 24 hours

Secondary Outcomes (1)

• Requirment of analgesic drugs either (opoid or non opoid) postoprative by Viscual Analogue Scale (VAS) Score

  Requirment of analgesic drugs either (opoid or non opoid) postoprative. in 24hours

Study Arms (2)

group A lumber electrospine plane block

ACTIVE COMPARATOR

20ml of 0.25% bupivacaine will be injected into the interfascial plane between the erector spinae muscle and L5 transverse process.

Drug: 0.25% bupivacaine

group B fascia iliaca plane block

ACTIVE COMPARATOR

a total of 20 mL of 0.25% bupivacaine will be slowly injected in fascia iliaca

Drug: 0.25% bupivacaine

Interventions

0.25% bupivacaine DRUG

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

Also known as: 0.25% isobaric bupivacaine

group A lumber electrospine plane block; group B fascia iliaca plane block

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age between ≥ 18 years
• Both sexes.
• American Society of Anesthesiologists (ASA) Physical Status I-III
• Undergoing elective unilateral hip surgeries under spinal anesthesia
• Patients with body mass index (BMI) \< 35 kg/m²

You may not qualify if:

• Patient refusal
• Known allergy to local anesthetics
• Infection at the site of block
• Coagulopathy or bleeding disorders
• Cognitive impairment affecting pain assessment
• Chronic opioid use
• Neuromuscular disorders as patients with stroke.

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

sohag University

Sohag, 82516, Egypt

Location

MeSH Terms

Interventions

Bupivacaine

Intervention Hierarchy (Ancestors)

Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines

Central Study Contacts

hadeer ali, resident

CONTACT

01115813875; doradoctora46@gmail.com

Study Design

• Study Type: interventional
• Phase: phase 4
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Masking Details: triple
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident at Anesthesia department

Model Details: compare fascia iliaca plane block versus lumbar Erectospinae plane block in hip replacement as Postoperative Analgesia arm 1 fascia iliaca plane block arm 2 lumber electrospine plane block A standardized analgesic regimen will be prescribed in the postoperative period. Patients will be observed at 0, 2, 4, 6, 12,18 and 24 hours for postoperative VAS scores. All patients will receive paracetamol 1 gm every 6 h as routine analgesia. If VAS is more than 3 intravenous morphine 3mg will be administered as rescue analgesia

Study Record Dates

• First Submitted: March 9, 2026
• First Posted: June 8, 2026
• Study Start: May 20, 2026
• Primary Completion (Estimated): November 28, 2026
• Study Completion (Estimated): November 28, 2026
• Last Updated: June 8, 2026

Record last verified: 2026-06

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)